Fast-food chain McDonald’s, an economic indicator because of its mammoth global presence, posted its worst earnings report since 2020.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
The warnings come as the industry adapts to seismic shifts in technology — which means it may just have some new tricks up its sleeve.
China is a top global producer of 30 of the 50 minerals the US considers critical, and is sources more than half of the US annual supply.
With Hollywood conquered, Netflix has a new goal: reach a $1 trillion market cap by 2030, according to a Wall Street Journal report.
Novo Nordisk, maker of weight-loss drug Wegovy, struck a deal with online telehealth storefronts that sold cheap knockoffs during shortages.
As a share of US GDP, the manufacturing sector has decreased from a nearly 25% peak in the 1950s to about 11% today.
A handful of retail executives hinted this week that they are eyeing some strategic advantages and opportunities amid the trade war.
While Kuiper won’t generate revenue for a while, Amazon is still using its enormous influence to position itself for some corporate Star Wars.
Reducing beverage-wait times is part of Starbucks CEO Brian Niccol’s turnaround plan, which includes tech updates focused on efficiency.
A Minecraft Movie is lighting the box office on fire. It’s a much-needed win for the battered Warner Bros Discovery.
Airline stocks are in a prolonged nosedive: Delta, American, and United have each fallen 35 to 45% this year.
Elon Musk’s departure from the Department of Government Efficiency still remains something of an “if,” not a “when.”
To prepare for a slowdown of global trade, US retailers spent months building a massive inventory to prevent empty shelves.
Hertz’s recent track record leaves much to be desired: the rental-car company lost nearly $2.9 billion last year.
Investor worries about a fresh batch of US tariffs have dragged LVMH shares in Paris down 23.6% so far this year.
The company plans to seek regulatory approval for the revolutionary weight loss treatment by the end of the year.